Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

State Key Laboratory of Natural and Biomimetic Drugs, Chemical Biology Center and School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Rd, Beijing 100191, China ...

They found hundreds of thousands of regulatory regions, called enhancers, that help turn genes on and off in plants. They also saw that maize has a few thousand “super enhancers.” Each ...

circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (over 400 patents and patent applications ...

and promoter-associated long RNA. They have also been classified according to the position of the lncRNA in the genome relative to the target protein-coding gene as 1) antisense lncRNA, which is ...

They could also consist of enhancer of zeste homolog 2 (EZH2), be a suppressor of zeste 12 (SUZ12 ... MDSCs are a heterogeneous population of immature myeloid cells with immunosuppressive ...

RNA polymerase binds to a region just before the gene, called the promoter, before moving down the DNA to the gene. Enhancers are regions of DNA that act as molecular switches for turning genes on ...

Development of this therapeutics is based on promising technologies such as RNA interference technology (RNAi), antisense technology. Moreover, Cancer diagnosis and treatment is currently undergoing a ...

RNA polymerase binds to a region just before the gene, called the promoter, before moving down the DNA to the gene. Enhancers are regions of DNA that act as molecular switches for turning genes on or ...

RNA polymerase binds to a region just before the gene, called the promoter, before moving down the DNA to the gene. Enhancers are regions of DNA that act as molecular switches for turning genes on or ...